Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

Delayed Data
As of Jul 21
 +0.04 / +0.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 7.50, with a high estimate of 9.50 and a low estimate of 3.50. The median estimate represents a +59.57% increase from the last price of 4.70.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.34%
Growthannually 22.77%


Growthquarterly 31.83%
Growthannually 14.97%
Key to the earnings and sales forecast charts.